Midday movers: Travelers, JB Hunt fall; United Airlines rises
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
U.S. Bancorp (USB) PT Lowered to $43 at UBS
April 19, 2024 6:34 AM EDTUBS analyst Erika Najarian lowered the price target on U.S. Bancorp (NYSE: USB) to $43.00 (from $47.00) while maintaining a Neutral rating.
The analyst comments "USB underperformed Tuesday down 3.6% while the BKX finished up 0.7% after lowering its full year PPNR outlook as a greater than... More
Chip stocks, including Nvidia, 'have ways to go to the downside' - Lynx
April 18, 2024 8:26 AM EDTIn a Thursday note to clients, a Lynx Equity Strategies analyst said the firm believes semiconductor chip stocks, including NVIDIA (NASDAQ: NVDA), "have ways to go to the downside."
Travelers (TRV) PT Lowered to $225 at RBC Capital
April 18, 2024 6:21 AM EDTRBC Capital analyst Mark Dwelle lowered the price target on Travelers (NYSE: TRV) to $225.00 (from $230.00) while maintaining a Sector Perform rating.
The analyst comments "Although Q1 results were impacted by larger-than-normal catastrophe losses, we viewed the overall y/y core margin improvement across... More
Abbott Labs (ABT) PT Lowered to $125 at RBC Capital
April 18, 2024 6:19 AM EDTRBC Capital analyst Shagun Singh lowered the price target on Abbott Labs (NYSE: ABT) to $125.00 (from $128.00) while maintaining a Outperform rating.
The analyst comments "ABT delivered a Q1 Rev/EPS upside of $80MM/$0.03, respectively, and tightened its FY24 guidance range. Despite a strong Q1... More
United Continental (UAL) PT Raised to $70 at BofA Securities
April 18, 2024 5:49 AM EDTBofA Securities analyst Andrew Didora raised the price target on United Continental (NASDAQ: UAL) to $70.00 (from $60.00) while maintaining a Buy rating.
The analyst comments "UAL shares were +18% today on a strong 1Q24 earnings beat and 2Q24 EPS outlook (see our first... More
U.S. Bancorp (USB) PT Lowered to $48 at Wells Fargo
April 18, 2024 5:33 AM EDTWells Fargo analyst Mike Mayo lowered the price target on U.S. Bancorp (NYSE: USB) to $48.00 (from $50.00) while maintaining a Overweight rating.
The analyst comments "NII flattening albeit w/worse guide. USB guided NII 1%-3% lower than where it was before (from... More
United Continental (UAL) PT Raised to $80 at Citi
April 18, 2024 4:50 AM EDTCiti analyst Stephen Trent raised the price target on United Continental (NASDAQ: UAL) to $80.00 (from $73.00) while maintaining a Buy rating.
The analyst comments "Forecast adjustments for Buy-rated United Airlines include the incorporation of stronger, expected revenue per available seat mile or RASM,... More
J.B. Hunt Transport Services (JBHT) PT Lowered to $200 at BMO Capital
April 17, 2024 4:09 PM EDTBMO Capital analyst Fadi Chamoun lowered the price target on J.B. Hunt Transport Services (NASDAQ: JBHT) to $200.00 (from $218.00) while maintaining a Outperform rating.
The analyst comments "The immediate term is challenged and the current bid season may still prove to be... More
Travelers (TRV) PT Lowered to $202 at Goldman Sachs
April 17, 2024 3:48 PM EDTGoldman Sachs analyst Alex Scott lowered the price target on Travelers (NYSE: TRV) to $202.00 (from $212.00) while maintaining a Sell rating.
The analyst comments "In our view, TRV's share price reaction today (-8% currently) reflects investor focus on additions to liability reserves for recent accident years in Business Insurance plus... More
Travelers (TRV) PT Lowered to $235 at CFRA
April 17, 2024 12:41 PM EDTCFRA analyst Cathy Seifert lowered the price target on Travelers (NYSE: TRV) to $235.00 (from $240.00) while maintaining a Buy rating.
The analyst comments "We trim our 12-month target price by $5 to $235, valuing the shares at 11.3x our 2025 operating EPS estimate of $20.75 (raised by $0.80) and at... More
Travelers (TRV) PT Lowered to $214 at Morgan Stanley
April 17, 2024 12:28 PM EDTMorgan Stanley analyst Bob Huang lowered the price target on Travelers (NYSE: TRV) to $214.00 (from $230.00) while maintaining a Equalweight rating.
The analyst comments "Elevated loss ratio in Business Insurance and elevated expenses in Bond & Specialty insurance drove the earnings miss. Slower than... More
Eli Lilly (LLY) sleep apnea study data seen as a win, stock gains
April 17, 2024 11:12 AM EDTEli Lilly & Co. (NYSE: LLY) announced positive topline results from its SURMOUNT-OSA Ph3 study on Wednesday, which evaluated tirzepatide compared to placebo in patients with obesity and sleep apnea.
According to the company, the phase 3 clinical trials that showed tirzepatide injection significantly reduced the... More
Travelers (TRV) PT Raised to $220 at JPMorgan
April 17, 2024 9:57 AM EDTJPMorgan analyst Jimmy Bhullar raised the price target on Travelers (NYSE: TRV) to $220.00 (from $213.00) while maintaining a Underweight rating.
The analyst comments "TRVs reported relatively healthy business trends in 1Q24, but earnings missed consensus projections (beat our forecast). Elevated cat losses offset... More
Travelers (TRV) stock falls on earnings, revenue miss
April 17, 2024 9:29 AM EDTShares of Travelers (NYSE: TRV) fell 7% following the announcement of their first-quarter results, which missed analyst estimates for both earnings per share (EPS) and revenue. The insurance giant reported an adjusted EPS of $4.69, which was $0.18 shy of the consensus estimate of $4.87. Earned premiums for the quarter were reported at $10.13 billion, falling below the expected $10.62 billion.
Despite the shortfall relative to analyst expectations, Travelers did see a year-over-year (YoY) increase in its financials.... More
Morgan Stanley (MS) PT Raised to $109 at Jefferies
April 17, 2024 8:41 AM EDTJefferies analyst Daniel Fannon raised the price target on Morgan Stanley (NYSE: MS) to $109.00 (from $107.00) while maintaining a Buy rating.
The analyst comments "Post 1Q24 results, we increase our EPS est's for 2Q24/2024 to $1.74/$7.25 from $1.59/$6.50 previously. Positive revisions reflect continued strength in IB... More
